Xylem Inc. Q2 2026 Earnings Report: Key Financials & Shareholder Insights

Summary of Key Points

• Quarter End: June 30, 2026
• Common Stock Outstanding: 233,486,812 shares as of July 24, 2026
• Revenue: Xylem Inc. reported robust revenues for both the three and six months ended June 30, 2026
• Net Operating Income: Significant improvement in operating income compared to prior periods
• Cost and Expense Trends: SG&A, R&D, and restructuring charges are disclosed in detail
• Shareholder Structure: No evidence of shell company status, and the company maintains its status as a large accelerated filer
• Stock Listing: Shares are listed on the NYSE under the symbol XYL
• Price-Sensitive Items: Restructuring and asset impairment charges, operational gains, and sale of business losses

Detailed Financial Performance

Income Statement Highlights

Shareholder Structure & Regulatory Status

• Xylem Inc. maintains compliance with all SEC reporting requirements and has submitted all required Interactive Data Files.
• Company is not a shell company and is classified as a large accelerated filer, suggesting strong regulatory standing and market presence.
• Shares are registered with the NYSE under the symbol XYL.
• No evidence of small business or emerging growth company status.

Potential Price-Sensitive and Shareholder-Relevant Issues

• Restructuring and Asset Impairment: Charges increased to \$47M for the six months ended June 30, 2026, which may signal operational changes, potential cost savings, or streamlining initiatives. This is a material change that investors should monitor for impact on future earnings.
• Sale of Business Losses: A loss of \$12M was recognized, possibly indicating divestitures or business exits. This could have implications for future earnings and business focus.
• Operating Performance: Operating income rose to \$634M for six months, compared to \$536M in the prior period. This improvement is generally positive and could support share price appreciation if sustained.
• Revenue & Profitability: Revenues remained stable, with only a slight decrease compared to the previous year. However, cost control and operating efficiency appear to have improved.
• Share Repurchase Program: There are references to active share repurchase plans, which can support share price and shareholder value.

Outlook & Investor Considerations

Investors should note the following:

• Stable revenues and improving operating income might be viewed positively by the market.
• Restructuring and asset impairment charges are material and could signal further operational changes or cost reductions, but may also reflect short-term expenses that could impact profit margins.
• Losses on sale of business units, while not large, indicate some portfolio reshaping and could affect future growth prospects.
• The company remains compliant with all regulatory requirements and continues to be listed as a large accelerated filer, reinforcing its standing in the market.
• Share repurchase programs may provide direct support to share price and enhance shareholder value.

Shareholder Actions

Shareholders are advised to monitor further updates from Xylem Inc. regarding restructuring, asset impairments, and business divestitures, as these may have direct effects on profitability and share price. The company’s strong compliance and reporting status, coupled with its robust operating performance, are positive indicators. However, any further restructuring or asset sales should be watched closely for their impact on future financial results.

Disclaimer: The information provided above is based on the most recent quarterly SEC filings by Xylem Inc. and is intended for informational purposes only. It does not constitute investment advice. Investors should review the full SEC filings and consult with financial advisors before making any investment decisions.

View Xylem Inc. Historical chart here